[Hazards of the neuro-muscular blocking effect of antibiotics].
D000109:Acetylcholine / Q000502:physiology; D000758:Anesthesia / Q000009:adverse effects; D000777:Anesthetics / Q000009:adverse effects; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000009:adverse effects*; D002118:Calcium / Q000627:therapeutic use; D003091:Colistin / Q000009:adverse effects; D006801:Humans; D007223:Infant; D007612:Kanamycin / Q000009:adverse effects; D008297:Male; D008875:Middle Aged; D009355:Neomycin / Q000009:adverse effects; D009469:Neuromuscular Junction / Q000503:physiopathology; D010243:Paralysis / Q000139:chemically induced* / Q000188:drug therapy / Q000503:physiopathology; D011113:Polymyxins / Q000009:adverse effects; D012131:Respiratory Insufficiency / Q000139:chemically induced*; D012133:Respiratory Paralysis / Q000139:chemically induced / Q000188:drug therapy / Q000503:physiopathology; D013307:Streptomycin / Q000009:adverse effects; D013572:Synaptic Vesicles
D000777:Anesthetics; D000900:Anti-Bacterial Agents; D011113:Polymyxins; D007612:Kanamycin; D009355:Neomycin; D000109:Acetylcholine; D002118:Calcium; D013307:Streptomycin; D003091:Colistin
Die Gefhren der neuromuskulärblockierenden Wirkung von Antibiotica.